Question: Please describe this drug.
Description: The Compound has the SMILES CCN(CC)CCOc1ccc(Cc2ccccc2)cc1.
Answer: Tesmilifene is a novel potentiator of chemotherapy which, when added to doxorubicin, achieved an unexpected and very large survival advantage over doxorubicin alone in a randomized trial in advanced breast cancer.
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCN(CC)CCOc1ccc(Cc2ccccc2)cc1
CCN(CC)CCOC1=CC=C(C=C1)CC2=CC=CC=C2
2-(4-benzylphenoxy)-N,N-diethylethanamine
Please describe this drug.
Tesmilifene is a novel potentiator of chemotherapy which, when added to doxorubicin, achieved an unexpected and very large survival advantage over doxorubicin alone in a randomized trial in advanced breast cancer.